Skip to main content
Premium Trial:

Request an Annual Quote

Number Crunch: Feb 1, 2001

Premium

Recent data from Paolo P. Saviotti, Marie Angele de Looze, Sylvie Michelland, and David Catherine show the growth and spread of bioinformatics firms.

Tech Fields Using Bioinformatics

PHARMACEUTICALS 21%

GENOMICS 12%

AGRICULTURE 11%

BIOLOGICALS 7%

DIAGNOSTICS 6%

CHEMICALS 5%

ENVIRONMENTAL 2%

Other 34%

Bioinformatics Startups, 1961 - 1998

Year /Specialized Firms /Non specialized firms /Total Creation firms

1961 0 1 1
1967 0 1 1
1971 1 0 1
1978 1 0 1
1979 0 1 1
1981 1 1 2
1982 1 1 2
1983 1 0 1
1984 2 1 3
1985 1 0 1
1986 0 2 2
1988 0 1 1
1989 2 4 6
1990 2 2 4
1991 2 1 3
1992 2 6 8
1993 9 5 14
1994 3 5 8
1995 7 1 8
1996 6 3 9
1997 14 11 25
1998 17 6 23

Where Are the Bioinformatics Companies?

Belgium 2%
Canada 3%
Germany 16%
France 5%
Netherlands 1%
Sweden 1%
UK 7%
US 62%
Israel 1%

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.